Effective Single Twymeeg Administration for Elderly Patient with Type 2 Diabetes (T2D), Arthralgia and Depression as Common Medical Problems-Reference-Cited by-同舟云学术

Effective Single Twymeeg Administration for Elderly Patient with Type 2 Diabetes (T2D), Arthralgia and Depression as Common Medical Problems

Published:2022-06-06 Issue:1 Volume:4 Page:1-7
ISSN:
Container-title:Diabetes Research: Open Access
language:en
Short-container-title:Diab Res Open Access

Author:

OKADA Masaki¹,BANDO Hiroshi²^ORCID,IWATSUKI Noboru¹,SAKAMOTO Kazuki¹,OGAWA Tomoya¹

Affiliation:

1. Sakamoto Hospital, Higashi Kagawa city, Kagawa, Japan

2. Sakamoto Hospital, Higashi Kagawa city, Kagawa, Japan; Tokushima University / Medical Research, Tokushima, Japan; Japan Low Carbohydrate Diet Promotion Association, Kyoto, Japan

Abstract

Background: Imeglimin (Twymeeg) has been effective for patients with type 2 diabetes (T2D). Case Presentation: The patient is an 82-year-old female with T2D, arthralgia, and depression. Results: She was given duloxetine hydrochloride (Cymbalta) and Twymeeg, leading to improved symptoms of low back pain (LBP), knee osteoarthritis, osteoporosis, depression, and possible mild cognitive impairment (MCI). HbA1c decreased from 8.8% to 7.1% for 4 months with a single administration of Twymeeg 2000mg/day. Discussion: In recent clinical practice, elderly cases often tend to have simultaneously these problems, which are medical and social crucial problems. Twymeeg and Cymbalta may be indispensable agents for future practice.

Publisher

Asploro Open Access Publications

Reference32 articles.

1. American Diabetes Association. Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers. Clin Diabetes. 2022 Jan;40(1):10-38. [PMID: 35221470]

2. Ogurtsova K, Guariguata L, Barengo NC, Ruiz PL, Sacre JW, Karuranga S, Sun H, Boyko EJ, Magliano DJ. IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract. 2022 Jan;183:109118. [PMID: 34883189]

3. Le P, Ayers G, Misra-Hebert AD, Herzig SJ, Herman WH, Shaker VA, Rothberg MB. Adherence to the American Diabetes Association’s Glycemic Goals in the Treatment of Diabetes Among Older Americans, 2001-2018. Diabetes Care. 2022 May 1;45(5):1107-15. [PMID: 35076695]

4. American Diabetes Association. Introduction: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 Jan 1;45(Suppl 1):S1-S2. [PMID: 34964812]

5. American Diabetes Association Professional Practice Committee, Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 Jan 1;45(Suppl 1):S125-43. [PMID: 34964831]